Fixed Dosing of Leuprolide Acetate, a GnRH Agonist, in Children with Central Precocious Puberty: A Population Pharmacokinetic Justification
Pediatric Drugs · 2026-05 · 28 (3) · 295-305
DOI: 10.1007/s40272-025-00733-2 ↗Kurz gefasst
Klinische Studie (Phase III) in der Zeitschrift Pediatric Drugs, online erschienen am 13.03.2026. Verfasst von Chay Ngee Lim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pharmacology, AbbVie Inc., 1 North Waukegan Road, North Chicago, IL, 60064-1802, USA. Hauptthemen laut MEDLINE: Gonadotropin-Releasing Hormone, Leuprolide, Models, Biological, Puberty Inhibitors. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: AbbVie.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Clinical Pharmacology, AbbVie Inc., 1 North Waukegan Road, North Chicago, IL, 60064-1802, USA.
- Clinical Pharmacology, AbbVie Inc., 1 North Waukegan Road, North Chicago, IL, 60064-1802, USA. sale0074@umn.edu.
- Clinical Pharmacy, Ain Shams University, Cairo, Egypt. sale0074@umn.edu.
Förderung
- AbbVie
Zitieren
APA
Lim, C. N., Al Yacoub, O. N., Mostafa, N. M., & Salem, A. H. (2026). Fixed Dosing of Leuprolide Acetate, a GnRH Agonist, in Children with Central Precocious Puberty: A Population Pharmacokinetic Justification. Pediatric Drugs, 28(3), 295-305. https://doi.org/10.1007/s40272-025-00733-2
Vancouver
Lim CN, Al Yacoub ON, Mostafa NM, Salem AH. Fixed Dosing of Leuprolide Acetate, a GnRH Agonist, in Children with Central Precocious Puberty: A Population Pharmacokinetic Justification. Pediatric Drugs. 2026;28(3):295-305. doi:10.1007/s40272-025-00733-2
BibTeX
@article{Lim2026,
author = {Lim, Chay Ngee and Al Yacoub, Omar N and Mostafa, Nael M and Salem, Ahmed Hamed},
title = {Fixed Dosing of Leuprolide Acetate, a GnRH Agonist, in Children with Central Precocious Puberty: A Population Pharmacokinetic Justification},
journal = {Pediatric Drugs},
year = {2026},
volume = {28},
number = {3},
pages = {295--305},
doi = {10.1007/s40272-025-00733-2}
}
EUVIMED